Article info
Recent advances in clinical practice
Failure of reflux inhibitors in clinical trials: bad drugs or wrong patients?
- Correspondence to Dr Peter J Kahrilas, Northwestern University, Feinberg School of Medicine, Division of Gastroenterology and Hepatology, Department of Medicine, 676 N St Clair Street, 14th Floor, Chicago, IL 60611, USA; p-kahrilas{at}northwestern.edu
Citation
Failure of reflux inhibitors in clinical trials: bad drugs or wrong patients?
Publication history
- First published June 8, 2012.
Online issue publication
May 31, 2019
Article Versions
- Previous version (31 May 2019).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2012, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.